Mass General Brigham has unveiled its vision for Mass General Brigham Cancer, a new approach aimed at “helping patients navigate their entire journey of care, from prevention and early detection to treatment and survivorship.”
One of the principal goals of this new approach is to put “health equity at the center to support underserved communities.” Anne Klibanski, president and CEO of Mass General Brigham, states that “patients are living longer, with cancer becoming a chronic disease, and personalized treatments are more possible than ever. Our vision for Mass General Brigham Cancer is responsive to current and future trends in the cancer landscape and draws on our unique strengths to deliver the best care throughout our patients’ lives.”
The new strategy involves several core tenets, including “commitment to equity,” “early diagnosis and rapid intake,” “integrated [and] longitudinal care,” “advancing discovery and innovation,” and “research-driven treatment.” O’Neil Britton, chief integration officer at Mass General Brigham, says that the center will offer access to “cutting-edge clinical trials, novel therapies, and supportive services, as well as personalized and compassionate care.”
